Company Sidigali's Pharma Med S.r.l. with Fiscal Code 39439908
recorded a turnover of 2024 of
749.587,
with a net profit of
147.001
and having an average number of employees of
4.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Sidigali's Pharma Med S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
16.740
273.675
310.907
411.224
387.309
462.424
749.587
Total Income - EUR
-
-
-
16.740
274.738
323.546
429.395
397.979
490.927
776.112
Total Expenses - EUR
-
-
-
7.870
115.837
231.954
261.760
374.336
397.106
606.191
Gross Profit/Loss - EUR
-
-
-
8.870
158.901
91.592
167.635
23.643
93.822
169.921
Net Profit/Loss - EUR
-
-
-
8.368
156.159
88.859
164.277
19.753
90.689
147.001
Employees
-
-
-
0
1
1
1
2
3
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 63.0%, from 462.424 euro in the year 2023, to 749.587 euro in 2024.
The Net Profit increased by 56.819 euro, from 90.689 euro in 2023, to 147.001 in the last year.
Check the financial reports for the company - Sidigali's Pharma Med S.r.l.
Financial Rating - SIDIGALI'S PHARMA MED S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Sidigali's Pharma Med S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Sidigali's Pharma Med S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Sidigali's Pharma Med S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Sidigali's Pharma Med S.r.l. - CUI 39439908
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
0
660
31.811
60.868
177.526
126.172
261.276
Current Assets
-
-
-
22.641
162.923
168.933
219.443
215.508
269.730
473.369
Inventories
-
-
-
6.883
11.909
24.216
61.995
83.846
179.881
172.308
Receivables
-
-
-
16.625
119.921
83.664
74.685
84.131
55.072
192.324
Cash
-
-
-
-868
31.093
61.053
82.763
47.531
34.778
108.737
Shareholders Funds
-
-
-
8.722
156.507
157.567
241.097
20.221
110.919
257.300
Social Capital
-
-
-
355
348
341
334
335
404
402
Debts
-
-
-
13.919
7.076
43.177
39.214
372.813
284.983
477.344
Income in Advance
-
-
-
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
473.369 euro in 2024 which includes Inventories of
172.308 euro, Receivables of
192.324 euro and cash availability of
108.737 euro.
The company's Equity was valued at
257.300 euro, while total Liabilities amounted to
477.344 euro.
Equity increased by 147.001 euro, from 110.919 euro in 2023, to 257.300 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sidigali's Pharma Med S.r.l.